<DOC>
	<DOCNO>NCT00478517</DOCNO>
	<brief_summary>The social , psychological , economic burden Spinal trauma deficit great , curative treatment . Erythropoetin ( EPO ) promising , due neuroprotective effect demonstrate vitro , vivo animal model preliminary study include patient stroke . The study primary end point find maximum tolerate dose EPO . This base occurrence pulmonary embolism 14 day delay follow EPO injection . Secondary end point include comparison EPO kinetics blood cerebrospinal fluid ( CSF ) , study EPO effect several inflammatory apoptotic bio marker blood cell count . The experimental design dose scale study ( 600 2400 UI/Kg ) , use single dose rHuEPO , ( EPREX® ) . The EPO dose define use Bayesian continuous reassessment Method ( CRM ) . The sample size expect less 20 patient . Eligible patient patient age 15 65 year , able receive EPO injection within 12 hour spinal trauma , without vital blood loss associate disease . The follow-up last 6 month .</brief_summary>
	<brief_title>TETRAM 2 . Treatment With Erythropoetin Patients With Spinal Trauma With Neurological Deficit , Maximum Tolerated Dose Study</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Neurologic Manifestations</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Patient , male female , age 15 65 year , cover social insurance system , give informed consent ( attested third person unable sign , parent consent minor ) , within 12 hour spinal trauma , without vital organ deficiency non spinal origin Impaired consciousness , Treatment give within 12 hour , Cervical arthritis , Respiratory failure require artificial ventilation , Patient require blood transfusion superior 2 unit , Uncontrolled severe hypertension , Unstable hemodynamics , Patient suffer epilepsy , Recent uncontrolled angina pectoris , Having receive high dos glucorticoïds , Pregnant breasting , With 15 g/ml haemoglobin , With previous thrombo embolism disease , With allergy Low molecular Weight heparin , Participating another interventional study</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Spinal trauma</keyword>
	<keyword>erythropoietin</keyword>
	<keyword>dose escalation study</keyword>
</DOC>